Mavupharma Alternatives & Competitors
12 companies similar to Mavupharma — Pioneering non-nucleotide modulators of the STING pathway for cancer and infecti...
Companies similar to Mavupharma
AlloMek Therapeutics LLC
Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.
Tyligand Bioscience
Innovative small molecule therapeutics for cancer and autoimmune disease treatment.
Aurora Oncology
Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precisi...
Tract Bio
Discovering and developing novel therapies to transform the treatment of cancer and inflam...
Boston, United States
Track all Mavupharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
OnKure Therapeutics
Discovering and developing best in class precision medicines for the treatment of cancer
Boulder, United States
Apros Therapeutics, Inc.
Apros Tx is a drug discovery and development company focused on immunotherapeutics for can...
San Diego, United States
Hemispherian AS
Hemispherian is a biotechnology company developing new treatments for the most aggressive...
Oslo, Norway
辽宁依生生物制药有限公司
Pioneering groundbreaking biotherapeutics for cancers and infectious diseases with innovat...
Abion Inc.
ABION, pioneering precision oncology in lung cancer and infectious disease solutions
Seoul, Korea South
NEC OncoImmunity AS
Empowering cancer immunotherapy with artificial intelligence
Oslo, Norway
ESPERANCE PHARMACEUTICALS, INC.
Pioneering a new era of anticancer treatment with drugs that precisely target and eliminat...
PMV Pharmaceuticals, Inc.
Harnessing the power of p53 to treat cancer
Princeton, United States
About Mavupharma
Mavupharma is a biotechnology startup that is pioneering non-nucleotide modulators of the STING pathway for cancer and infectious disease treatment. Founded in 2016, the company is focused on developing non-nucleotide, conditional modulators of the STING pathway to address critical medical needs in the fields of Biotec...
Cancer Treatment, Infectious Disease Treatment, STING Pathway Modulators, Drug Development, Precision Medicine
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Mavupharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Mavupharma on 11 Sep 2024. The 12 companies listed here were last checked between 22 Jun 2024 and 12 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
